Evidence Hub

S2118 Seven-Day Tegoprazan Therapy Matches Proton Pump Inhibitors and 14-Day Therapies for H. pylor Eradication With Much Fewer Adverse Events: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Ashesh Das, Venkata Dileep Kumar Veldi, Muqadas Bhatti, Y. Nasit, S. Madduri, A. A. Hanchate, Sai Madhav Dongur, S. Chelluri et al.

American Journal of Gastroenterology, 2025

1,668 participants

Abstract

Introduction: Despite guideline-mandated 14-day quadruple therapy, real-world eradication of Helicobacter pylori continues to falter because proton-pump inhibitors (PPIs) give slow, CYP2C19-dependent acid control and carry growing clarithromycin resistance. Potassium-competitive acid blockers such as tegoprazan achieve near-instant, sustained pH > 6 and have delivered non-inferior or superior cure rates in trials while shortening therapy duration and mitigating dyspepsia-related toxicity. Whether a 7-day tegoprazan-based course can match conventional PPI or longer tegoprazan regimens and simultaneously improve tolerability remains a clinically pivotal question for stewardship. Methods: A systematic search of PubMed, Embase, Scopus, and Cochrane Library identified Randomized Controlled Trials (RCTs) comparing 7-day tegoprazan Therapy versus PPIs or 14-day regimens for H. pylori eradication through May 2025. Data were analyzed using RevMan 4.2.1. Pooled risk ratios (RRs) with 95% confidence intervals (CIs) were calculated using Mantel-Haenszel methods. Random- or fixed-effects models were applied based on heterogeneity (Higgins’ I²). Statistical significance was set at P < 0.05. Risk of bias was assessed using RoB 2.0. Results: Four RCTs (n = 1,668; 7-day tegoprazan = 841, control = 827) showed identical eradication efficacy confirmed by urea breath test (RR 0.99, 95% CI 0.94-1.04; I² = 0%) with the abbreviated tegoprazan regimen. Serious adverse events (SAEs) fell by 40% (RR…

How strong is the evidence?

Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 1,668 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free